## 5.1 Inclusion Criteria

Participants will be eligible to be included in the study only if all of the following criteria apply:
## Age
Participant must be greater than 18 years of age.
## Type of Participant and Disease Characteristics
Must be a consecutive patient with a newly diagnosed, objectively confirmed:
Symptomatic or unsuspected proximal lower-limb DVT, or
Symptomatic PE, or
Unsuspected PE in a segmental or more proximal pulmonary artery.
Must have any type of cancer (excluding basal-cell or squamous-cell carcinoma of the skin,
primary brain tumor, known intracerebral metastases, and acute leukemia) that meets at
least one of the following criteria:
Active Cancer:
Diagnosis of cancer within six months before study inclusion, or
receiving treatment for cancer at the time of inclusion, or any treatment for cancer
during the 6 months prior to randomization, or recurrent locally advanced or metastatic
cancer. Active cancer will also be defined as meeting any of the following criteria: (1)
nonsquamous cell or basal cell invasive cancer diagnosed within 6 months before
enrollment, (2) cancer treated within the previous 6 months, (3) recurrent or metastatic
cancer, or (4) active cancer during the study.
History of Cancer:
Cancer diagnosed within 2 years before study inclusion.
## Weight
No specific weight or BMI criteria were provided in the source document.
## Sex and Contraceptive/Barrier Requirements
Both male and female participants will be eligible. Contraceptive requirements for women of
childbearing potential are detailed in the exclusion criteria.
## Informed Consent
Signed informed consent as described in Appendix 1 which includes compliance with the
requirements and restrictions listed in the informed consent form (ICF) and in this protocol.